National and Kapodistrian University of Athens
Ανοσολογική απάντηση έναντι της ηπατίτιδας Α σε εμβολιασθέντες ασθενείς με HIV-1 λοίμωξη
Abstract
dc:descriptionThe natural history of HIV-infection has been altered due to the use of Highly Active Antiretroviral Therapy [HAART]. Survival and quality of life of HIV-infected patients have increased. However HIV-patients are still at great risk of some vaccine-preventable diseases especially these diseases which have sexual transmission. Hepatitis A remains a public health problem and is of special concern in HIV-infected patients, especially MSM and intravenous drug users. Hepatitis A is considered to be a self-limited disease but immunocompromised individuals may experience serious complications. The most effective intervention in preventing disease is vaccination Success of hepatitis A vaccination in HIV-infected patients is an important issue for good clinical care.The immune system dysfunction in HIV-infection iw extensive and multifactorial. The immune response upon vaccination is generally impaired in HIV-infected patients. . The aim of this study was to evaluate the immune response to hepatitis A vaccine, the factors that may affect the response and vaccination’s effect to HIV-infection parameters. Eligibility criteria included CD4 T-cell counts more than 200cells/mm3 at the time of vaccination.351 HIV-infected MSM men were recruited to the study. Anti-HAV antibody titers were determined with a commercial enzyme-linked fluorescent assay method [VIDAS Anti-HAV Total, Biomerieux, France] at month 1, 6, 12 and 18 after the second dose of vaccine. CD4, CD8 T-, NK-, B-cells counts and HIV RNA level were determined 1 month after second dose of vaccine . Seroconversion occurred 1 month after the second dose of HAV vaccine in74.4% [260/351] of the cases. Seroprotective titers of anti-HAV antibodies were measured in 68.4%, 61.2 % and 56.1% at months 6, 12 and 18 respectively. Those who responded had significantly higher CD4 T-cell counts at the time of vaccination than those who didn’t respond [580 cells/mm3 vs. 528 cells/mm3] .There was no significant difference to response rate between patients with plasma HIV RNA<50copies/ml [response rate:71%] and those with higher viral load [response rate:70%].Anti-HAV geometric mean titer [GMT] showed a significant decrease among repeated measurements [p-value<1%]. In addition, patients with CD4 T-cell counts above 500 cells/mm3 at vaccination, had higher GMTs compared with subjects with CD4=200-499 cells/mm3No significant changes in CD4 T-cell counts and other immunological parameters or the plasma HIV-1 RNA were observed postvaccination.Several factors like HIV-RNA, nadir CD4 count, history of HAART, history of an AIDS- defining condition, age, smoking status and BMI were evaluated for their effect to immune response. Logistic regression revealed that the only factor affecting response is the CD4 T-cell count at vaccination [p=0.019].Although patients with high CD4 T-cell count [especially those with CD4 T-cell >500 cells/mm3] are supposed to have sufficient immune system, our study demonstrates that a number of HIV-patients, even those with high CD4 counts, do not respond to the hepatitis A vaccine. It is then confirmed that immune dysfunction in HIV-infection is multifactorial and the determination of the number of CD4 T cells helps quantify immune status but it is not an accurate predictor of immune response to vaccines Furthermore, new challenges arise, concerning guidelines for administration strategies for non-responders and those with no detectable antibodies should be evaluated
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kourkounti, Sofia
- Κουρκουντή, Σοφία
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29694